Phase 1b/2a Safety and Pharmacokinetic Study of G1T28 in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC) Receiving Etoposide and Carboplatin Chemotherapy - Regional Cancer Care Associates LLC

Clinical Trials

Phase 1b/2a Safety and Pharmacokinetic Study of G1T28 in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC) Receiving Etoposide and Carboplatin Chemotherapy

Type of Cancer
Lung
Locations
Bethesda
Sponsor
G1 Therapeutics
Protocol Number
G1T28-02
Cancer Diagnosis
To Learn More Call
201-510-0910